Alternative therapies and the Di Bella affair in pediatrics. A questionnaire submitted to Italian pediatric oncologists and hematologists

Haematologica

Volumn 85, Issue 2, 2000, Pages 189-194

  Burgio, G Roberto ^a   Locatelli, Franco ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Alternative therapies; Bioethics; Childhood neoplasia; Di Bella therapy; Leukemia

Indexed keywords

ALTERNATIVE MEDICINE; ARTICLE; ATTITUDE; CANCER RECURRENCE; CANCER THERAPY; CHILDHOOD CANCER; DOCTOR PATIENT RELATION;

CHILD; CHILD, PRESCHOOL; COMPLEMENTARY THERAPIES; HEMATOLOGIC NEOPLASMS; HUMANS; ITALY; QUESTIONNAIRES;

EID: 0034043915     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Risberg T, Bremnes RM, Wist E, Kaasa S, Jacobsen BK. Communicating with and treating cancer patients: how does the use of non-proven therapies and patients' feeling of mental distress influence the interaction between the patient and the hospital staff. Eur J Cancer 1997; 33:883-90.
2. Gray RE, Fitch M, Greenberg M. A comparison of physician and patient perspectives on unconventional cancer therapies. Psycho-oncology 1998; 7:445-52.
3. Stoll BA. Can unorthodox cancer therapy improve quality-of-life? Ann Oncol 1993; 4:121-3.
4. Burke C, Sikora K. Complementary and conventional cancer care: the integration of two cultures. Clin Oncol (R Coll Radiol) 1993; 5:220-7.
5. Downer SM, Cody MM, McCluskey P, et al. Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. Br Med J 1994; 309:86-9.
6. DeTrill M, Kovalcik R. The child with cancer. Influence of culture on truth-telling and patient care. Ann NY Acad Sci 1997; 809:197-210.
7. Fernandez CV, Stutzer CA, MacWilliam L, Fryer C. Alternative and complementary therapy use in pediatric oncology patients in British Columbia: prevalence and reasons for use and nonuse. J Clin Oncol 1998; 16:1279-86.
8. Sawyer MG, Gannoni AF, Toogood IR, Antoniou G, Rice M. The use of alternative therapies by children with cancer. Med J Australia 1994; 160:320-2.
9. Grootenhuis MA, Last BF, de Graaf-Nijkerk JH, vander-Wel M. Use of alternative treatment in pediatric oncology. Cancer Nurs 1998; 21:282-8.
10. Holland JC. Use of alternative medicine-a marker for distress? N Engl J Med 1999; 340:1758-9.
11. Bet A, Herbert C. Two solitudes of complementary and conventional medicine. Where are we going? Can Fam Physician 1998; 44:953-5 and 960-2.
12. Grothey A, Duppe J, Hasenburg A, Voigtmann R. [Use of alternative medicine in oncology patients]. Dtsch Med Wochenschr 1998; 123:923-9.
13. Coppes MJ, Anderson RA, Egeler RM, Wolff JE. Alternative therapies for the treatment of childhood cancer. N Engl J Med 1998; 339:846-7.
14. Montbriand MJ. The 1996 Schering Lecture. An inquiry into the experience of oncology patients who leave biomedicine to use alternate therapies. Can Oncol Nurs J 1997; 7:6-13.
15. Montbriand MJ. Abandoning biomedicine for alternate therapies: oncology patients' stories. Cancer Nurs 1998; 21:36-45.
16. Salmenpera L, Suominen T, Lauri S. Oncology nurses' attitudes towards alternative medicine. Psychooncology 1998; 7:453-9.
17. Remuzzi G, Schieppati A. Lessons from the Di Bella affair. Lancet 1999; 353:1289-90.
18. Evaluation of an unconventional cancer treatment (the Di Bella multitherapy): results of phase II trials in Italy. Italian Study Group for the Di Bella Multitherapy Trails2E Br Med J 1999; 318: 224-8.
19. Abbasi K. Di Bella's miracle method. Br Med J 1998; 516:1617.
20. Reyes JL. Compared to what? [eLetter]. eBr Med J; 22 January 1999.
21. Müllner M. Di Bella's therapy: the last word? The evidence would be stronger if the researchers had randomised their studies. Br Med J 1999; 318:208-9.
22. Brera GR, Violato C. Methodological and ethical difficulties in clinical oncology studies. Lancet 1998; 352: 1391.
23. Raschetti R, Bruzzi P. Methodological and ethical difficulties in clinical oncology trials. Di Bella Multitreatment Italian Trial Coordinating Group. Lancet 1999; 353:153-4.
24. Raschetti R. We totally disagree with Müllner's view. [eLetter]. eBr Med J, 8 February 1999.
25. Raschetti R, Greco D, Menniti-Ippolito F, Spila-Alegiani S, Benagiano G, Bruzzi P. The Di Bella multitherapy trial. Criticism ignores standard methodology of cancer treatments. Br Med J 1999; 318:1074.
26. Liberati A. Missing the forest while looking at the tree. [eLetter]. eBr Med J, 17 February 1999.
27. Liberati A, Magrini N, Patoia L, Pagliaro L. The Di Bella multitherapy trial. Randomised controlled trials may not always be absolutely needed. Br Med J 1999; 318:1073-4.
28. Müllner M, Ewans SJW. The Di Bella multitherapy trial. Reply from author and statistical adviser. Br Med J 1999; 318:1074.
29. Pellegrini R. Di Bella's method of curing cancer is becoming popular in Italy. Br Med J 1998; 317:352.
30. Simini B. Frenzy mounts in Italy over assessment of the Di Bella regimen. Lancet 1998; 351:891.
31. Milano G. "Caso" Di Bella: a proposito di etica del-l'informazione. [The "Di Bella" story: some thoughts about the ethics of information]. Epid Prev 1998; 22: 82-4.
32. Sermonti G. Di Bella - candidate failed before the exam? Riv Biol 1998; 91:367-9.
33. Di Filippo F, Serraino D, Tirelli U. [Evaluation study of the opinions on the Di Bella multi-therapy (MDB) of tumour patients]. Clin Ther 1998; 149:261-5.
34. Di Vito F. Di Bella: un caso anomalo [Di Bella: an anomalous case]. Epidemiol Prev 1998; 22:142-5.
35. Burgio GR. Terapia Di Bella e dintorni. Creare una cultura medica dei non-medici. Pediatria Notizie 1999; 6:1-2.
36. Burgio GR. Non giova il silenzio di chi può parlare in nome della scienza. Occhio Clinico - Pediatria 1999; 3:3-6.
37. Burgio GR, Notarangelo LD. La comunicazione in Pediatria. Un pediatra per la società. Milano: UTET; 1999.
38. Yeoh C, Kiely E, Davies H. Unproven treatment in childhood oncology - how far should paediatricians co-operate? J Med Ethics 1994; 20:75-6.
39. Jackson J. Unproven treatment in childhood oncology - how far should pediatricians co-operate? J. Med. Ethics 1994; 20:77-9.
40. Locatelli F, Rocha V, Chastang C, et al. Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-Cord Blood Transplant Group. Blood 1999 93:3662-71.
41. Zecca M, Pession A, Messina C, et al. Total body irradiation, thiotepa and cyclophosphamide as a conditioning regimen for children with acute lymphoblastic leukemia in first or second remission undergoing bone marrow transplantation with HLA-identical siblings. J Clin Oncol 1999; 17:1838-46.
42. Uderzo C, Rondelli R, Dini G, et al. High-dose vincristine, fractionated total-body irradiation and cyclophosphamide as conditioning regimen in allogeneic and autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in second remission: a 7-year Italian multicentre study. Br J Haematol 1995; 89:790-7.
43. Dini G, Lanino E, Lamparelli T, et al. Unrelated donor marrow transplantation: initial experience of the Italian bone marrow transplant group (GITMO). Bone Marrow Transplant 1996, 17:55-62.
44. Pession A, Prete A, Locatelli F, et al. Immunotherapy with low-dose recombinant interleukin 2 after high-dose chemotherapy and autologous stem cell transplantation in neuroblastoma. Br J Cancer 1998; 78: 528-33.
45. Garaventa A, Ladenstein R, Chauvin F, et al. High-dose chemotherapy with autologous bone marrow rescue in advanced stage IV neuroblastoma. Eur J Cancer 1993; 29:487-91.
46. Garaventa A, Hartmann O, Bernard JL, et al. Autologous bone marrow transplantation for pediatric Wilms' tumor: the experience of the European Bone Marrow Transplantation Solid Tumor Registry. Med Pediatr Oncol 1994; 22:11-4.